Actuate Therapeutics, Inc. (ACTU) stock
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.02 (-6.12%)
Close on Nov 17, 2026Market cap $6.04MP/E –Yield –
Actuate Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Actuate Therapeutics's total assets was $3.22M at Sep 30, 2026. For fiscal 2025 it was $14.04M, up 50.6% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.04M | +50.6% |
| FY2024 | Dec 31, 2024 | $9.32M | +211.1% |
| FY2023 | Dec 31, 2023 | $3.00M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.22M | -81.8% |
| Q2 FY2026 | Jun 30, 2026 | $5.20M | -25.4% |
| Q1 FY2026 | Mar 31, 2026 | $8.91M | +98.8% |
| Q4 FY2025 | Dec 31, 2025 | $14.04M | +50.6% |
| Q3 FY2025 | Sep 30, 2025 | $17.71M | +24.2% |
| Q2 FY2025 | Jun 30, 2025 | $6.97M | +302.6% |
| Q1 FY2025 | Mar 31, 2025 | $4.48M | +49.7% |
| Q4 FY2024 | Dec 31, 2024 | $9.32M | – |
| Q3 FY2024 | Sep 30, 2024 | $14.26M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.73M | – |
| Q4 FY2023 | Dec 31, 2023 | $3.00M | – |
See a number that looks wrong?